ONCT NASDAQ
Oncternal Therapeutics, Inc.
1W: +0.0%
1M: -24.1%
3M: -57.9%
1Y: -94.6%
3Y: -98.9%
5Y: -99.4%
$0.53
Last traded 2024-12-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$37M
-46.5% ▼
5Y CAGR: +3.2%
Total Liabilities
$7M
-13.1% ▼
5Y CAGR: +5.1%
Shareholders Equity
$30M
+119.0% ▲
5Y CAGR: +2.9%
Cash & Investments
$34M
-46.2% ▼
5Y CAGR: +3.8%
Total Debt
$318K
+265.5% ▲
5Y CAGR: -63.1%
Net Debt
-$6M
+82.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $20M | $117M | $91M | $37M | $7M |
| Short-Term Investments | $0 | $0 | $0 | $27M | $28M |
| Cash & ST Investments | $20M | $117M | $91M | $64M | $34M |
| Net Receivables | $0 | $0 | $944K | $178K | $632K |
| Inventory | $0 | $0 | $0 | $103K | $0 |
| Other Current Assets | $736K | $1M | $359K | $0 | $606K |
| Total Current Assets | $21M | $118M | $93M | $67M | $36M |
| Property, Plant & Equip. | $190K | $40K | $75K | $87K | $258K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $767K | $766K | $657K | $1M | $412K |
| Total Non-Current Assets | $957K | $806K | $732K | $1M | $670K |
| Total Assets | $22M | $119M | $94M | $69M | $37M |
| — Liabilities — | |||||
| Accounts Payable | $871K | $1M | $2M | $3M | $1M |
| Short-Term Debt | $99K | $0 | $0 | $0 | $0 |
| Deferred Revenue | $4M | $2M | $0 | $0 | $0 |
| Other Current Liabilities | $2M | $2M | $0 | $0 | $2M |
| Total Current Liabilities | $7M | $6M | $5M | $8M | $5M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $1M |
| Total Non-Current Liabilities | $91K | $0 | $0 | $3M | $1M |
| Total Liabilities | $7M | $6M | $5M | $8M | $7M |
| — Equity — | |||||
| Common Stock | $15K | $49K | $49K | $57K | $3K |
| Retained Earnings | -$66M | -$83M | -$114M | -$158M | -$198M |
| Accumulated OCI | $0 | -$0 | $0 | $9K | $3K |
| Total Stockholders Equity | $14M | -$83M | -$114M | -$158M | $30M |
| Total Liabilities & Equity | $22M | -$77M | -$109M | $69M | $37M |
| — Key Metrics — | |||||
| Total Debt | $190K | $40K | $75K | $87K | $318K |
| Net Debt | -$20M | -$117M | -$91M | -$37M | -$6M |
| Total Investments | $0 | $0 | $0 | $27M | $28M |